Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure

Journal of Cardiology

Volumn 59, Issue 3, 2012, Pages 366-373

  Nishi, Kiyoto ^a,b   Sato, Yukihito ^a   Miyamoto, Tadashi ^a   Toma, Masanao ^a   Taniguchi, Ryoji ^a   Fukuhara, Rei ^a   Saijo, Sayaka ^a   Fujiwara, Hisayoshi ^a   Takatsu, Yoshiki ^a  

^a HYOGO PREFECTURAL AMAGASAKI GENERAL MEDICAL CENTER   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Cost effectiveness; Heart failure; Inotropic agents; Natriuretic peptides

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR ALPHA; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; LOPRINONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIASTOLIC BLOOD PRESSURE; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEALTH CARE COST; HEART FAILURE; HOSPITALIZATION; HUMAN; MALE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT; URINE VOLUME;

AGED; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIOTONIC AGENTS; DOBUTAMINE; DOPAMINE; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; IMIDAZOLES; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; OUTPATIENTS; PYRIDONES; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; SYSTOLE; TREATMENT OUTCOME;

EID: 84860478119     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2012.01.008     Document Type: Article

References (25)

1. Ahmed A., Allman R.M., Fonarow G.C., Love T.E., Zannad F., Dell'italia L.J., White M., Gheorghiade M. Incident heart failure hospitalization and subsequent mortality in chronic heart failure: a propensity-matched study. J Card Fail 2008, 14:211-218.
2. Chaudhry S.I., Wang Y., Krumholz H.M., Gill T.M., Krumholz H.M. Patterns of weight change preceding hospitalization for heart failure. Circulation 2007, 116:1549-1554.
3. Yu C.M., Wang L., Chau E., Chan R.H., Kong S.L., Tang M.O., Christensen J., Stadler R.W., Lau C.P. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005, 112:841-848.
4. GESICA Investigators Randomised trial of telephone intervention in chronic heart failure (DIAL trial). BMJ 2005, 331:425-427.
5. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., Oates J.A., Rahko P.S., Silver M.A., Stevenson L.W., Yancy C.W., et al. ACC/AHA 2005 Guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-e235.
6. Cesario D., Clark J., Maisel A. Beneficial effect of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. Am Heart J 1998, 135:121-129.
7. Adamopoulos S., Piepoli M., Qiang F., Pissimissis E., Davies M., Bernardi L., Forfar C., Sleight P., Coats A. Effects of pulsed β-stimulant therapy on β-adrenoceptors and chronotropic responsiveness in chronic heart failure. Lancet 1995, 345:344-349.
8. Bayram M., Luca L.D., Massie M.B., Gheorghiade M. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 2005, 96:47G-58G.
9. Yancy C.W., Krum H., Massie B.M., Silver M.A., Stevenson L.W., Cheng M., Kim S.S., Evans R., FUSION II Investigators Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial. Congest Heart Fail 2008, 1:9-16.
10. Abraham W.T., Adams K.F., Fonarow G.C., Costanzo M.R., Berkowitz R.L., LeJemtel T.H., Cheng M.L., Wynne J., ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005, 46:57-64.
11. Nishi K., Sato Y., Miyamoto T., Taniguchi R., Matsuoka T., Kuwabara Y., Isoda K., Yamane K., Hatakenaka T., Fujinaga K., Fujiwara H., Takatsu Y. Infusion therapy at outpatient clinic in chronic end-stage heart failure. J Cardiol 2007, 49:251-258. (in Japanese).
12. Allen L.A., Hernandez A.F., O'Connor C.M., Felker G.M. End points for clinical trials in acute heart failure syndromes. J Am Coll Cardiol 2009, 53:2248-2258.
13. Sanada S., Kitakaze M., Papst P.J., Asanuma H., Node K., Takashima S., Asakura M., Ogita H., Liao Y., Sakata Y., Ogai A., Fukushima T., Yamada J., Shinozaki Y., Kuzuya T., et al. Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase. Circulation 2001, 104:705-710.
14. Hayashi M., Tsutamoto T., Wada A., Maeda K., Mabuchi N., Tsutsui T., Horie H., Ohnishi M., Kinoshita M. Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction. J Am Coll Cardiol 2001, 37:1820-1826.
15. Nohria A., Mieliniczuk L.M., Stevenson L.W. Evaluation and monitoring of patients with acute heart failure syndromes. Am J Cardiol 2005, 96:32G-40G.
16. Dickstein K., Cohen-Solal A., Filippatos G., McMurray J.J., Ponikowski P., Poole-Wilson P.A., Strömberg A., van Veldhuisen D.J., Atar D., Hoes A.W., Keren A., Mebazaa A., Nieminen M., Priori S.G., Swedberg K., et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008, 29:2388-2442.
17. Maeda K., Tsutamoto T., Wada A., Mabuchi N., Hayashi M., Tsutsui T., Ohnishi M., Sawaki M., Fujii M., Matsumoto T., Kinoshita M. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coll Cardiol 2000, 36:1587-1593.
18. Ryder M., Murphy N.F., McCaffrey D., O'Loughlin C., Ledwidge M., McDonald K. Outpatient intravenous diuretic therapy; potential for marked reduction in hospitalizations for acute decompensated heart failure. Eur J Heart Fail 2008, 10:267-272.
19. Gheorghiade M., Abraham W.T., Albert N.M., Greenberg B.H., O'Connor C.M., She L., Stough W.G., Yancy C.W., Young J.B., Fonarow G.C., OPTIMIZE-HF Investigators and Coordinators Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA 2006, 296:2217-2226.
20. Metra M., Torp-Pedersen C., Swedberg K., Cleland J.G., Di Lenarda A., Komajda M., Remme W.J., Lutiger B., Scherhag A., Lukas M.A., Charlesworth A., Poole-Wilson P.A. Influence of heart rate, blood pressure, and beta-blocker dose on outcome and the differences in outcome between carvedilol and metoprolol tartrate in patients with chronic heart failure: results from the COMET trial. Eur Heart J 2005, 26:2259-2268.
21. Anker S.D., Negassa A., Coats A.J., Afzal R., Poole-Wilson P.A., Cohn J.N., Yusuf S. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet 2003, 361:1077-1083.
22. Davos C.H., Doehner W., Rauchhaus M., Cicoira M., Francis D.P., Coats A.J., Clark A.L., Anker S.D. Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. J Card Fail 2003, 9:29-35.
23. Honda T., Kanazawa H., Koga H., Miyao Y., Fujimoto K. Heart rate on admission is an independent risk factor for poor cardiac function and in-hospital death after acute myocardial infarction. J Cardiol 2010, 56:197-203.
24. Kuwahata S., Miyata M., Fujita S., Kubozono T., Shinsato T., Ikeda Y., Hamasaki S., Kuwaki T., Tei C. Improvement of autonomic nervous activity by Waon therapy in patients with chronic heart failure. J Cardiol 2011, 57:100-106.
25. Poole-Wilson P.A., Uretsky B.F., Thygesen K., Cleland J.G., Massie B.M., Rydén L., Atlas Study Group Assessment of treatment with lisinopril and survival. Mode of death in heart failure: findings from the ATLAS trial. Heart 2003, 89:42-48.